{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:18:00Z","timestamp":1776431880433,"version":"3.51.2"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.reprotox.2006.05.009","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T17:13:22Z","timestamp":1149700402000},"page":"578-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment"],"prefix":"10.1016","volume":"22","author":[{"given":"Asher","family":"Ornoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rivka","family":"Wajnberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orna","family":"Diav-Citrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2006.05.009_bib1","first-page":"18","article-title":"Pharmacogenetics of alendronate: an overview","volume":"101","author":"Lin","year":"1999","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/j.reprotox.2006.05.009_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/07853899708998743","article-title":"Biphosphonates: preclinical aspects and use in osteoporosis","volume":"29","author":"Fleisch","year":"1977","journal-title":"Ann Med"},{"key":"10.1016\/j.reprotox.2006.05.009_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H","article-title":"Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats","volume":"60","author":"Patlas","year":"1999","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2006.05.009_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bdra.10016","article-title":"No effects of bisphosphonates on the human fetus","volume":"67","author":"Rutgers-Verhage","year":"2003","journal-title":"Birth Defects Res Part A: Clin Mol Teratol"},{"key":"10.1016\/j.reprotox.2006.05.009_bib5","first-page":"359","article-title":"Fetal outcome after intrauterine exposure to bisphosphonates","volume":"70","author":"Levy","year":"2004","journal-title":"Birth Defects Res Part A: Clin Mol Teratol"},{"issue":"3","key":"10.1016\/j.reprotox.2006.05.009_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.reprotox.2005.04.007","article-title":"Intrauterine growth restriction; etiology and consequences: what do we know about the human situation and experimental animal models","volume":"20","author":"Ergaz","year":"2005","journal-title":"Reprod Toxicol"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623806001328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623806001328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:24:54Z","timestamp":1760189094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623806001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0890623806001328"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2006.05.009","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2006.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}